Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion type Assertion NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_head.
- NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion wasGeneratedBy ECO_0000203 NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_provenance.
- NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion wasDerivedFrom befree-2016 NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_provenance.
- NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion SIO_000772 21944383 NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_provenance.
- NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion evidence source_evidence_literature NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_provenance.
- NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_provenance.